Current Research Studies
Randomized Controlled Trial of Valganciclovir for Asymptomatic Cytomegalovirus Infected Hearing Impaired Infants (ValEAR Trial)
ValEAR
- Phase: II
- Clinicaltrials.gov ID: NCT03107871
What is the goal of the study?
To learn more about this study, please email the study team member listed below.
Who can participate in the study?
Please contact the study team listed below to learn more.
Study Team:
- PI (Study Doctor): Ann Melvin
- Study Team Member: Amanda Robson, [email protected]